C3TR01 Consulta CRT-P
Cardiac Resynchronization Therapy - Pacing (CRT-Pacing)
C3TR01 Consulta CRT-P

Device Survival Probability


    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr at 93.0 mo    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 99.9 99.9 99.9 99.9    
% Including Normal Battery Depletion 99.9 99.8 99.5 98.1 95.8 91.8 84.2 58.7    
#   26671 23951 21390 18233 14209 9522 3922 374    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Customer Communications For This Model

  • There are no communications for this model.

Product Characteristics

Generator Type CRT-Pacing
Max. Delivered Energy N/A
Connector Style CRT-P Style
Serial Number Prefix PZI
Mass 26 g
Volume 15 cc
Waveform N/A
Hide this content
CRT-P Style

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 8.7 10.7
Nominal 3.5 V (A, RV) 6.0 8.2
High 5.0 V (A, RV) 3.3 5.1

Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; Left Ventricle Pulse Width 0.4 ms; Left Ventricle Pulse Amplitude same as A, RV; Left Ventricle Percent Paced 100 %; Left Ventricle Lead Impedance same as A, RV; EGM Prestorage ON ; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %Hide this content


Distribution Data

US Market Release
CE Approval Date2010-05-11
Registered USA Implants2
Estimated Active USA Implants2
Normal Battery Depletions
US Market Release
CE Approval Date2010-05-11
Estimated WW Distribution27408
Normal Battery Depletions11

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised

Malfunctions (WW)

Therapy Function Not Compromised 4
Battery 1
Electrical Component 2
Electrical Interconnect 1
Therapy Function Compromised 0

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.


Recommended Replacement (RRT)

Battery voltage less than or equal to 2.77V on 3 consecutive daily automatic measurments.

Data as of October 29, 2020

www.medtronic.com/productperformance 776050